Purchase vaccines for vaccination services in 2025

After reconciliation, 1 dose (0.5ml) contains 120mcg of RSVPREF3 antigen that is added with AS01E. RSVPREF3: Glycoprotein F of the respiratory microscopic microorganisms (RSV) is stable in the form of consolidated currency RSVPREF3. AS01E supplementary system includes Quillaja Saponaria Molina extract, segment 21 (QS-21) 25MCG and 3-O-DESACYL-4’-Monophosphoryl Lipid A (MPL) from Salmonella Minnesota 25 mcg

1

After reconciliation, 1 dose (0.5ml) contains 120mcg of RSVPREF3 antigen that is added with AS01E. RSVPREF3: Glycoprotein F of the respiratory microscopic microorganisms (RSV) is stable in the form of consolidated currency RSVPREF3. AS01E supplementary system includes Quillaja Saponaria Molina extract, segment 21 (QS-21) 25MCG and 3-O-DESACYL-4’-Monophosphoryl Lipid A (MPL) from Salmonella Minnesota 25 mcg

Intramuscularly

Powder and phase mixture

Box

10

Each dose (0.5 ml) contains: - Synthetic protein (Fition Protein) NHBA NHBA NHBA Neisseria MENINGITIDIS group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. - Synthetic protein FHBP Neisseria Meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg

1

Each dose (0.5 ml) contains: - Synthetic protein (Fition Protein) NHBA NHBA NHBA Neisseria MENINGITIDIS group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. - Synthetic protein FHBP Neisseria Meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg

Intramuscularly

Injection

Box

10

Each dose of 0.5ml after reconciliation contains 50mcg antigens GE recombinant of the Varicella Zoster virus (VZV) is supplemented with AS01B

1

Each dose of 0.5ml after reconciliation contains 50mcg antigens GE recombinant of the Varicella Zoster virus (VZV) is supplemented with AS01B

Intramuscularly

Lyophilized powder and suspension for injection

Box

10

One dose (0.5ml) contains 1 mcg polysaccharide of serum types 11,2, 51,2, 6b1,2, 7f1,2, 9v1,2, 141,2, 23f1,2 and 3 mcg of serum types 41.2, 18C1.3, 19f1,4

1

One dose (0.5ml) contains 1 mcg polysaccharide of serum types 11,2, 51,2, 6b1,2, 7f1,2, 9v1,2, 141,2, 23f1,2 and 3 mcg of serum types 41.2, 18C1.3, 19f1,4

Intramuscularly

Injection

Dose

100

After reconstitutioning 01 dose (0.5ml) contains: Diphore detox ≥ 30iu; Tetanintic detox ≥ 40iu; Bordetella pertussis antigens include 25mcg pertussis detoxification and 25MCG and 8MCG -shaped red blood cells; Antigen surface of hepatitis B virus 10mcg; Virus polio type 1 inactivation (Mahoney) 40du; Inactive 2-type virus (MEF-1 strain) 8DU; Viral virus is inactive 3 (afterket) 32du; Haemophilus Influenza's polysaccharide category B 10mcg plus 25mcg tetanus detoxification such as carrier protein

1

After reconstitutioning 01 dose (0.5ml) contains: Diphore detox ≥ 30iu; Tetanintic detox ≥ 40iu; Bordetella pertussis antigens include 25mcg pertussis detoxification and 25MCG and 8MCG -shaped red blood cells; Antigen surface of hepatitis B virus 10mcg; Virus polio type 1 inactivation (Mahoney) 40du; Inactive 2-type virus (MEF-1 strain) 8DU; Viral virus is inactive 3 (afterket) 32du; Haemophilus Influenza's polysaccharide category B 10mcg plus 25mcg tetanus detoxification such as carrier protein

Intramuscularly

East dried powder (HIB) and mixed (DTPA-HBV-IPV) to mix the injection mixture

Dose

300

Raw measles virus, reduced poison (Schwarz strain); Virus of mumps, reducing poison (Rit 4385 strain); Rubella virus lives, reducing poison (Wistar strain to March 27)

1

Raw measles virus, reduced poison (Schwarz strain); Virus of mumps, reducing poison (Rit 4385 strain); Rubella virus lives, reducing poison (Wistar strain to March 27)

Subcutaneous

Dried injection

Box

1.000

One dose (0.5ml) contains: Diphore detox ≥ 2iu; Tetanintic detox ≥ 20iu; Bordetella pertussis antigens include 8MCG pertussis detoxification; Conducting red blood cells in 8mcg and pertactin 2.5mcg

1

One dose (0.5ml) contains: Diphore detox ≥ 2iu; Tetanintic detox ≥ 20iu; Bordetella pertussis antigens include 8MCG pertussis detoxification; Conducting red blood cells in 8mcg and pertactin 2.5mcg

Intramuscularly

Injection

Box

50

Each dose of 1.5ml contains Rotavirus in people who live to decrease toxic, RIX4414 ≥ 106.0 CCID50

1

Each dose of 1.5ml contains Rotavirus in people who live to decrease toxic, RIX4414 ≥ 106.0 CCID50

Drink

Drink

Tube

100

Each dose 1.0ml contains: Hepatitis A Antigen virus (HM175 Strain) 720 Elisa Units; R-DNA Hepatitis B Virus Surface Antigen (HBsAg) 20mcg

1

Each dose 1.0ml contains: Hepatitis A Antigen virus (HM175 Strain) 720 Elisa Units; R-DNA Hepatitis B Virus Surface Antigen (HBsAg) 20mcg

Intramuscularly

Injection

Box

50

Chickenpox virus reduces poison (strain OKA) ≥ 103.3 pfu

1

Chickenpox virus reduces poison (strain OKA) ≥ 103.3 pfu

Subcutaneous

Dried injection

Box

100

Inactivated virus (Pitman Moore strain, propagated on Vero cells)

5

≥ 2.5 IU/0.5ml

Intramuscularly

Box of 1 vial of single-dose lyophilized powder, 1 tube of 0.5ml reconstitution solvent and 1 sterile syringe, Lyophilized powder for injection, Intramuscular/intradermal injection

Jar

1.000

Polysaccharide Polyribosylribitolphosphate (PRP) plus with tetanus detoxification.

5

10 mcg PRP plus with (20.8-31.25 mcg) Tetetanic detoxification/0.5 ml

Intramuscularly

Box contains 25 vials of 0.5ml, Solution for injection, Intramuscular injection

Jar

450

Protein includes pure hepatitis A virus antigen

4

<100mcg/0.5ml

Intramuscularly

Box of 10 vials x 0.5ml (1 dose), Suspension for injection, Intramuscular injection

Jar

50

HBsAg surface protein (purity ≥ 95%)

5

20mcg/1ml

Intramuscular injection

Box of 25 vials x 20mcg/1ml, Suspension for injection, Deep intramuscular injection

Jar

850

HBsAg surface protein (purity ≥ 95%)

5

10mcg/0.5ml

Intramuscular injection

Box of 25 vials x 10mcg/0.5ml, Injection suspension, Deep intramuscular injection

Jar

2.050

- Pure antigen inactivating influenza A H1N1 - Pure antigen inactivating influenza A H3N2 - Pure antigen inactivating influenza virus B - Pure antigen inactivating influenza virus B

2

(Type A H1N1 - 15mcg; Type A H3N2 - 15mcg; Type B - 15mcg; Type B - 15mcg)/0.5ml

Intramuscularly

Box contains 10 prefilled syringes (0.5ml), Injection suspension, Intramuscular injection

Dose

1.950

Japanese encephalitis virus, pure (SA 14-14-2)

5

6mcg/0.5ml

Intramuscularly

Vaccine vial 6 mcg/0.5ml, Box of 10 vials. Suspension for injection, Intramuscular injection

Jar

1.950

Antibiotic antibodies against rabies

4

1000 IU/5ml

Intramuscularly

Box of 10 vials x 1000IU, Solution for injection, Intramuscular injection

Jar

100

Globulin resistant toxin tetanus toxin 1500 ĐVQT

4

Globulin resistant toxin tetanus toxin 1500 ĐVQT

Inject

Injection solution

Box of 20 tubes, two blisters x 1500 ĐVQT

950

Human Hepatitis B Immunoglobulin

1

180iu/ml

Inject

Injection

Box of 1 vial x1ml

50

A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010) 15mcg haemagglutinin, A/Victoria/4897/202 2 (H1N1)pdm09-like strain (A/Victoria/4897/20 22, IVR-238) 15mcg haemagglutinin, B/Austria/1359417/ 2021-like strain (B/Austria/1359417/ 2021, BVR-26) 15mcg haemagglutinin, B/Phuket/3073/2013 -like strain (B/Phuket/3073/201 3, wild type) 15mcg haemagglutinin

1

Each 0.5ml vaccine contains: A/Darwin/9/2021 (H3N2) -Like Strain (A/Darwin/9/2021, SAN-010) 15mcg HAemagglutinin, A/Victoria/4897/202 2 (H1N1) PDM09- Like Strain (A/Victoria/4897/20 22, IVR -238) 15MCG) 15MCG) Haemagglutinin, B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, BVR-26) 15MCG HAemagglutinin, B/Phuket/3073/2013 -Like Strain (B/Phuket/3073/201 3, Wild Type) 15MCG HAEMAGGLUTININININIIN

Inject

Injection

Box of 1 syringe contains 0.5 ml of suspension

2.900

Each syringe contains 1 single dose of 0.5ml containing: tube serum 1 polysaccharid pneumococcal bacteria 2.2mcg; Type 3 polysaccharide pneumococcal bacteria 2.2mcg; Type 4 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 5 polysaccharide pneumococcal bacteria 2.2mcg; Type 6A polysaccharide pneumococcal bacteria 2.2mcg; Type 6b polysaccharid pneumococcal pneumococcal pneumococcal pneumococcal. Type 7f polysaccharide pneumococcal bacteria 2.2mcg; Type 9V polysaccharide pneumococcal bacteria 2.2mcg; Type 14 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 18C polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 19A polysaccharid pneumococcal pneumococcal bacteria 2.2mcg; Type 19f polysaccharide pneumococcal bacteria 2.2mcg; Tip serum 23F polysaccharid pneumococcal bacteria 2.2mcg; CRM197 32MCG shipping protein

1

Each syringe contains 1 single dose of 0.5ml containing: tube serum 1 polysaccharid pneumococcal bacteria 2.2mcg; Type 3 polysaccharide pneumococcal bacteria 2.2mcg; Type 4 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 5 polysaccharide pneumococcal bacteria 2.2mcg; Type 6A polysaccharide pneumococcal bacteria 2.2mcg; Type 6b polysaccharid pneumococcal pneumococcal pneumococcal pneumococcal. Type 7f polysaccharide pneumococcal bacteria 2.2mcg; Type 9V polysaccharide pneumococcal bacteria 2.2mcg; Type 14 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 18C polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 19A polysaccharid pneumococcal pneumococcal bacteria 2.2mcg; Type 19f polysaccharide pneumococcal bacteria 2.2mcg; Tip serum 23F polysaccharid pneumococcal bacteria 2.2mcg; CRM197 32MCG shipping protein

Inject

Injection

Box of 1 prefilled syringe of 0.5ml with 1 needle

800

Each 2ml of solution contains: Rotavirus G1 Human-Bovine Rassortant; Rotavirus G2 Human-Bovine Rassortant; Rotavirus G3 Human-Bovine Rassortant; Rotavirus G4 Human-Bovine Rassortant; Rotavirus P1A [8] Human-Bovine Rassortant

1

≥ 2.2 million IU; ≥ 2.8 million IU; ≥ 2.2 million IU; ≥ 2.0 million IU; > 2.3 million IU

Drink

Drinking solution/ oral solution

Box of 10 bags x 1 2ml plastic tube; Box of 1 bag x 1 2ml plastic tube

100

Each dose (0.5 ml) contains 2mcg polysaccharids of the pneumococcal of serum types 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F and 4MCG Serum 6B plus with CRM197 transport protein, and adsorbed on aluminum supplements aluminum phosphate.

1

Each dose (0.5 ml) contains 2mcg polysaccharids of the pneumococcal of serum types 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F and 4MCG Serum 6B plus with CRM197 transport protein, and adsorbed on aluminum supplements aluminum phosphate.

Inject

Injection

Box 1 single -dose syringe pump with 0.5ml vaccine with 2 separate needles

20

Detoxification of refined tetanus

4

> = 40iu/tube

Inject

Injection

Box of 20 tubes (0.5ml/tube contains 01 dose of vaccine)

2.500

OKA/Merck Varicella Virus, Live, Attenuated> = 1350 PFU

1

OKA/Merck Varicella Virus, Live, ATTENATATED ≥ 1350pfu/vial; 0.5ml

Inject

East dried powder with solvent jar

Box of 1 single bottle of doses with 1 bottle of solvent

50

Each dose of 0.5ml reconstitution vaccine contains: Inactive rabies virus (Wistar Rabies PM/Wi 38 1503-3m) 3.25 IU (measured content according to international standards and Elisa testing)

1

3.25 IU/0.5ml/dose

Intramuscularly, injected in the skin

Dried injection

Jar

600

Each dose of 0.5ml contains hepatitis A virus, (GBM strain) inactivated 80U

1

Each dose of 0.5ml contains hepatitis A virus, (GBM strain) inactivated 80U

Intramuscularly

Injected injected in injection tools

Syringe

50

One dose (0.5ml) contains: Diphore detox ≥ 30 I.U.; Tetanic detox ≥ 40 I.u.; Bordetella pertussis antigens: Detoxifying pertussis (PT) 25 micrograms, fiber red blood cells (FHA) 25 micrograms; Viral paralysis (inactiveness): Type 1 (Mahoney) 40 du, type 2 (MEF-1) 8 Du, Type 3 (afterkett) 32 Du

1

One dose (0.5ml) contains: Diphore detox ≥ 30i.u.; Tetanintic detox ≥ 40i.u.; Bordetella pertussis antigens: Detoxifying pertussis (PT) 25 micrograms, fiber red blood cells (FHA) 25 micrograms; Viral paralysis (inactiveness): Type 1 (Mahoney) 40 du, type 2 (MEF-1) 8 Du, Type 3 (afterkett) 32 Du

Intramuscularly

Injected injected in injection tools

Syringe

100

Each dose of 0.5 ml contains: Diphore detoxification: No less than 20iu; Tetanintic detoxification: No less than 40iu; Bordetella pertussis antigen: Detoxifying pertussis (PT): 25mcg, fiber red blood cells (FHA): 25mcg; Polio virus (inactivated): Type 1 (Mahoney) 40 units of antigen D, Type 2 (MEF-1) 8 units of antigen D, type 3 (afterket) 32 units of antigen D; Hepatitis B surface antigen: 10mcg; Polysaccharide of Haemophilus Influenzae B (Polyribosylribitol phosphate): 12mcg plus tetanus protein 22-36mcg

1

Each dose of 0.5 ml contains: Diphore detoxification: No less than 20iu; Tetanintic detoxification: No less than 40iu; Bordetella pertussis antigen: Detoxifying pertussis (PT): 25mcg, fiber red blood cells (FHA): 25mcg; Polio virus (inactivated): Type 1 (Mahoney) 40 units of antigen D, Type 2 (MEF-1) 8 units of antigen D, type 3 (afterket) 32 units of antigen D; Hepatitis B surface antigen: 10mcg; Polysaccharide of Haemophilus Influenzae B (Polyribosylribitol phosphate): 12mcg plus tetanus protein 22-36mcg

Intramuscularly

Injected injected in injection tools

Syringe

350

1 dose (0.5 ml): Mocca polysaccharide (serum group A) (unit price plus) 4 µg (mcg); Moco brain polysaccharide (serum C) (unit price plus) 4 µg (MCG); Mocca polysaccharide (serum medical group) (unit price plus) 4 µg (mcg); Mocca polysaccharide (Serum group W-135) (Collective unit price) 4 µg (MCG); - Diphtheria detoxification protein (polysaccharide plus protein for all serum groups)* (* The amount of diphtheria detox is the estimated amount and depends on the ratio between polysaccharide plus and protein) 48 µg (MCG)

1

1 dose (0.5 ml): Mocca polysaccharide (serum group A) (unit price plus) 4 µg (mcg); Moco brain polysaccharide (serum C) (unit price plus) 4 µg (MCG); Mocca polysaccharide (serum medical group) (unit price plus) 4 µg (mcg); Mocca polysaccharide (Serum group W-135) (Collective unit price) 4 µg (MCG); - Diphtheria detoxification protein (polysaccharide plus protein for all serum groups)* (* The amount of diphtheria detox is the estimated amount and depends on the ratio between polysaccharide plus and protein) 48 µg (MCG)

Intramuscularly

Injection

Jar

100

Each dose of 0.5ml of vaccine (thin, inactive) contains: a/Victoria/4897/2022 (H1N1) PDM09 - Using the same strain (A/Victoria/4897/2022, IVR -238) 15 mcg HA; A/Darwin/9/2021 (H3N2) - Use equivalent strains (a/darkwin/9/2021, IVR -228) 15 mcg HA; B/Austria/1359417/2021 - Use equivalent strains (b/michigan/01/2021, wild strain) 15 mcg ha; B/phuket/3073/2013 - Use the same strain (b/phuket/3073/2013, wild strain) 15 mcg ha

1

Each dose of 0.5ml of vaccine (thin, inactive) contains: a/Victoria/4897/2022 (H1N1) PDM09 - Using the same strain (A/Victoria/4897/2022, IVR -238) 15 mcg HA; A/Darwin/9/2021 (H3N2) - Use equivalent strains (a/darkwin/9/2021, IVR -228) 15 mcg HA; B/Austria/1359417/2021 - Use equivalent strains (b/michigan/01/2021, wild strain) 15 mcg ha; B/phuket/3073/2013 - Use the same strain (b/phuket/3073/2013, wild strain) 15 mcg ha

Intramuscularly or subcutaneously

Injected injected in injection tools

Syringe

300

Each dose of 0.5ml contains: polysaccharide brain meningococcal (serum a) (unit price plus)* 10mcg; Mocca brain polysaccharide (serum C) (unit price plus)*10mcg; Mocca polysaccharide (Serum group W135) (Collective unit price)* 10mcg; Polysaccharide brain meningococcal (serum medical group) (unit price plus) * 10mcg * is added to the carrier is a tetanus detoxification protein about 55mcg

5

Each dose of 0.5ml contains: polysaccharide brain meningococcal (serum a) (unit price plus)* 10mcg; Mocca brain polysaccharide (serum C) (unit price plus)*10mcg; Mocca polysaccharide (Serum group W135) (Collective unit price)* 10mcg; Polysaccharide brain meningococcal (serum medical group) (unit price plus) * 10mcg * is added to the carrier is a tetanus detoxification protein about 55mcg

Intramuscularly

Injection

Jar

50

Cervical Cancer vaccine (9 strains)/0.5ml (GPLHSP; each 0.5ml dose contains 30 mcg L1 HPV protein type 6; 40mcg L1 HPV protein type 11; 60mcg L1 HPV protein type 16; 40mcg L1 HPV protein type 18, 20mcg L1 HPV protein each for types 31, 33, 45, 52 and 58

5

0.5ml

Intramuscularly

Injection

Jar

300